...
☀️ Warm Weather Notice: Refrigerated Orders Limited to 1-Month Supplies   MORE INFO

SAVE 10% OFF First Order With Coupon Code: WELCOME10

Call Toll Free

0

SAVE 10% OFF First Order With Coupon Code: WELCOME10

0

Our Price: $149.99

usa_flag Average USA Price: $248.60

Prescription Required
Cold Shipment This product is shipped in an insulated container with medical-grade ice packs.
Brand Name Product

Basaglar KwikPens

Refrigerated Orders: Limited to 1-Month Supplies.

Our Price: $149.99

usa_flag Average USA Price: $248.60

Questions?

How To Order Basaglar KwikPens

Step 1

Choose the Product and Add it to the Cart

The customer picks the required Basaglar dosage and quantity and adds the item to the cart. Additional diabetes supplies can be added as needed.

Step 2

Upload a Prescription

Patients must upload a clear photo or PDF during checkout for all prescription medications.

Step 3

Pharmacist Review and Verification

A licensed pharmacist reviews the order and verifies the prescription.

Step 4

Cold-Chain Packing and Shipping

The order is packed in temperature-controlled packaging - such as insulated boxes with ice packs - to maintain its integrity during transit once it is approved. Delivery typically takes 3-5 business days.

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.

Our Guarantee for Buying Basaglar Pens From Canada

Our Guarantee for Buying Basaglar Pens From Canada

Basaglar is a long-acting insulin used to help people with type 1 and type 2 diabetes maintain steady blood sugar control. Many patients choose to purchase Basaglar from Canada because prices can be up to 80% lower than typical U.S. pharmacy costs. Thousands of patients across the U.S. trust Insulin Outlet for its convenient online ordering process for a huge selection of name-brand diabetes medications at more affordable price points. A valid prescription is still required. Insulin Outlet partners only with licensed Canadian pharmacies and makes sure that all patients receive authentic and safely handled medication at a more affordable price.

Basaglar Drug Facts

Basaglar Drug Facts

Active Ingredient Insulin glargine
Type Long-Acting
Manufacturer Eli Lilly and Company
Onset About 1–2 hours after injection
Duration About 20–26 hours
Form Injectable pen (KwikPen or Tempo Pen)
Origin U.S.
Uses Blood sugar control in adults and children with type 1 diabetes and adults with type 2 diabetes
Administration Subcutaneous injection using a prefilled pen
Dosage Varies based on patient needs and blood glucose levels
Dosage Frequency Once daily (at the same time each day)
Storage
  • Refrigerate unopened pens (36°F–46°F / 2°C–8°C)
  • Opened pens may be kept at room temperature (up to 86°F / 30°C) for up to 28 days
About Basaglar Pens

About Basaglar Pens

This medication is a long-acting type of insulin that is prescribed to adults and children with type 1 diabetes. It is also prescribed to adults with type 2 diabetes. Basaglar is used to help these patients keep their blood glucose at healthy levels. This medication is delivered in the form of an injectable pen and is instructed to be used daily – at the same time each day.

Basaglar Benefits

Basaglar Benefits

  • Basaglar has been clinically proven to help lower and maintain stable blood glucose levels.
  • This medication offers long-lasting basal insulin coverage to support consistent blood sugar control.
  • Basaglar is often more affordable than many other long-acting insulin options.
  • Basaglar is approved by Health Canada for the treatment of diabetes.
Basaglar Pen Strengths and Dosages

Basaglar Pen Strengths and Dosages

Basaglar is available in U-100 (or 100 units/mL) strengths only. Patients specific dose of this medication may vary and is determined individually by their healthcare provider. Patients should take their doses at the same time each day unless their healthcare provider instructs them to do otherwise. This can be done by either using a KwikPen or a Tempo Pen.

How to Administer Basaglar Pens

How to Administer Basaglar Pens

  1. Take off the cap of the pen and wipe off the seal using an alcohol swab
  2. Take a new needle and remove the paper tab from the outside of it
  3. Insert the capped needle directly onto the pen and twist it until it is tightly in place
  4. Remove the outer needle shield and put it aside
  5. Remove the inner needle cap and discard it
  6. Turn the dose selector to two units to prime the pen
  7. Hold the pen upright with the needle pointing upward and then gently tap the cartridge to move any air bubbles to the top
  8. Continue to hold the pen in this direction and push in the dose knob until it stops and displays “0”
  9. Hold in the dose knob and slowly count to five
  10. Turn the dose knob until it displays the correct number (depending on the units prescribed to be injected)
  11. Choose the injection site for the dose
  12. Push in the needle into the chosen injection site and push the dose knob in the full way
  13. Press down the dose knob and do not release it until five seconds have passed
  14. Remove the needle from the skin and check the number displayed on the dose window to make sure it says “0”
  15. Replace the outer needle shield
  16. Unscrew the needle once it has been recapped and dispose of it in the appropriate container
  17. The pen cap should be placed back on the pen and the pen stored according to instructions

Some additional reminders include:

  • Double-check the insulin label before using it
  • Look at the pen before each dosage and only use it if it appears to be clear/colorless and free of particles
  • Take the medication at the same time each day
  • Inject the medication under the skin of the stomach, thigh, or upper arm
  • Rotate spots within the same area to help prevent skin thickening or lumps (and avoid any areas that already have these changes)
  • Routinely monitor blood sugar levels while on the medication
  • Never mix or dilute this medication with other insulins or solutions
Safety & Precautions

Safety & Precautions

Those taking this medication should make sure to never share their pens – regardless of whether or not a new needle is being used. Any changes to the patient’s insulin medication must be done under medical supervision and be supported by frequent glucose checks.

This medication may lead to hypoglycemia in some cases. This makes it extra important to increase monitoring during dose changes or when another glucose medication is being used. The same goes for when meal routines or activity levels shift and in patients with kidney or liver issues or reduced hypoglycemia awareness. Hypoglycemia may also occur if the wrong insulin is being used. The label of the medication should be confirmed before use of the medication.

Using Basaglar with thiazolidinediones may cause or worsen heart failure. Watch for symptoms and lower the dose or discontinue therapy if needed. Patients should also make sure to keep track of their potassium levels on this medication. Pens for this medication should never be shared between patients under any circumstances.

Common Side Effects

Patients taking Basaglar could experience several different side effects. The most common of these effects include:

  • Skin rash
  • Weight gain
  • Itching
  • Changes in the fat under the skin at injection sites
  • Swelling
  • Low blood sugar
  • Mild injection-site reactions
  • Allergic responses
  • Low blood sugar

Hypoglycemia may also occur in patients taking this medication and can be serious. It is important for patients to look out for signs of low blood sugar. They should also refrain from taking this medication if they are experiencing any symptoms of low blood sugar.

Severe Side Effects

Patients experiencing low blood sugar while taking this medication may experience side effects like:

  • Hunger
  • Sweating
  • Shaking or trembling
  • Mood changes
  • Dizziness
  • Headache
  • Confusion
  • Blurred vision
  • Rapid heartbeat
  • Slurred speech

Patients experiencing any of these side effects or having an allergic reaction to the medication should seek medical attention immediately.

Overdose/Missed Dose

Overdose/Missed Dose

Missed doses or underdosing of this medication may lead to blood sugar levels becoming too high. Patients should routinely monitor their blood sugar to make sure this does not happen. Doses of this medication should still never be doubled in order to make up for any missed doses. Taking too much of this medication can have the opposite effect and cause blood sugar levels to become dangerously low.

Storage of Basaglar Pens

Storage of Basaglar Pens

The insulin pens for this medication should be kept in the refrigerator – between 36°F and 46°F (or between 2°C and 8°C). These pens are not meant to be frozen and should not be used if they do become frozen. Pens of this medication that have been opened may be stored at room temperature for a maximum of 28 days. These pens still should not be stored at temperatures greater than 86°F (30°C).

Basaglar KwikPens vs. Alternatives

Basaglar KwikPens vs. Alternatives

Insulin Type Manufacturer Duration Concentration Injection Device
Basaglar Long-acting Eli Lilly and Company About 24 hours 100 units per 1 mL KwikPen or Tempo Pen
Lantus Long-acting Sanofi Up to 24 hours 100 units per 1 mL Vial or SoloStar pen
Toujeo Long-acting Sanofi Up to 36 hours 300 units per 1 mL SoloStar or Max Solostar pen
Why Buy Basaglar KwikPens from Insulin Outlet

Why Buy Basaglar KwikPens from Insulin Outlet

Patients buying their medication from Insulin Outlet experience:

  • Up to 80% savings on their medication’s U.S. prices
  • Real medications from licensed Canadian pharmacies
  • Flat $29.99 cold shipping
  • Medications and services with a 4.9-star average rating from more than 4,000 users

Buy Basaglar from Canada today.

Basaglar KwikPens

Basaglar KwikPens FAQs

Is a prescription needed for patients to order Basaglar?

Yes. Basaglar is a prescription-only insulin. A valid prescription must be uploaded during checkout before the pharmacy can process or ship the patient’s order.

Most Basaglar orders arrive within 3-5 business days once the prescription has been verified. Orders are shipped with temperature-controlled packaging to protect the medication during transit.

These medications are the same as long as the patient is purchasing the product that is manufactured by Eli Lilly. Both formulations contain the same active ingredient – insulin glargine. The only differences between the two medications are their packaging and pricing.

The exact dose depends on the type of diabetes for which the medication is being used for. It also may depend on factors such as age and weight. This is often anywhere from 0.2 units per kg up to 10 units per day.

Both Basaglar and Lantus are made with insulin glargine. This insulin is designed to provide long-acting glucose control. However, they are made by different manufacturers and come in different injection devices.

Pens should be refrigerated and kept within the 36°F to 46°F range prior to use. This is equivalent to being stored at temperatures between 2°C and 8°C. Basaglar pens can be kept at room temperature for up to 28 days – not exceeding 86°F (30°C) – once opened. Pens should not be used if they were ever frozen or exposed to excessive heat.

Disclaimer: The information provided on this page is for educational and informational purposes only and is not intended to replace professional medical advice or treatment. Basaglar is a prescription medication that must be used exactly as directed by a licensed healthcare provider.

Basaglar KwikPens

Sources

BASAGLAR KWIKPEN. (n.d.). DailyMed. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=0ad21db3-2b1c-4ed9-a687-bdd6a74d0aae

Basaglar® KwikPen®. (2025, April 24). Fairview Physician Associates Network. https://www.fpanetwork.org/device/basaglar-kwikpen/

Beabout, L.. (2025, May 22). Insulin prices: How much does insulin cost? SingleCare. https://www.singlecare.com/blog/insulin-prices/

Billingsley, A. (2024, February 20). Toujeo vs. Lantus: 6 Differences You Should Know. GoodRx. https://www.goodrx.com/conditions/diabetes-type-1/toujeo-vs-lantus

Brewer, A. (2025, July 16). Basaglar (insulin glargine) dosing schedule and details. https://www.medicalnewstoday.com/articles/drugs-basaglar-dosage#dosage-overview

Details for: BASAGLAR. (2025, December 8). Drug and Health Products Portal. https://dhpp.hpfb-dgpsa.ca/dhpp/resource/93005

Consumer information for: BASAGLAR. (2025, December 9). Drug and Health Products Portal. https://dhpp.hpfb-dgpsa.ca/dhpp/resource/93006/consumer-information

Highlights of Prescribing Information. (2021). Lilly and Company. https://pi.lilly.com/us/basaglar-uspi.pdf

Instructions for Use. (2022, August 26). Lilly. https://pi.lilly.com/ca/basaglar-80u-ca-ifu-kp.pdf

Long Acting Insulin For Diabetes | Lantus® (insulin glargine injection) 100 Units/mL. (n.d.). https://www.lantus.com/

TOUJEO® U-300 (insulin glargine) injection, for subcutaneous use Prescribing Information. (n.d.). Sanofi. https://products.sanofi.us/toujeo/toujeo.html

reviews

Reviews

Valid prescription required. Information provided for educational purposes only.
Customer Reviews
×

How would you like to contact us?

☀️ Summer Shipping Updates

As we enter the warmer summer months, we are making minor adjustments to our shipping protocols to ensure you receive your medications in the best possible condition.

Due to higher seasonal temperatures during transit, we are implementing the following changes:

  • Adjusted Supply Limits: We will be limiting Cold Chain Medications to 30-day supplies (with the exception of Ozempic, which is available in up to 60-day supplies).
  • Upgraded Packaging: For further security, we are transitioning from our standard medium-sized cold chain boxes to large-sized boxes for all cold chain medications.

Why are we doing this?

While these medications are generally stable at room temperature for 15 to 30 days, shorter shipping cycles and increased insulation mitigate heat exposure. These proactive steps significantly reduce the need for reshipments and guarantee your medication arrives safely.